The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group

Purpose of Review: The aim of this report is to summarize the conclusions of the II Regional Meeting on Histoplasmosis in the Americas held in Manaus, Brazil, on March 22–24, 2019. Recent Findings: Persons living with advanced HIV are at high risk for developing histoplasmosis. Clinical signs and sy...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2019
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23803
Acceso en línea:
https://doi.org/10.1007/s12281-019-00365-3
https://repository.urosario.edu.co/handle/10336/23803
Palabra clave:
Itraconazole
Acquired immune deficiency syndrome
Brazil
Clinical feature
Consensus development
Diagnostic test
Disease severity
Disease surveillance
Health care organization
Health care planning
Health program
High risk patient
Histoplasmosis
Human
Human immunodeficiency virus infected patient
Human immunodeficiency virus infection
In vitro study
International cooperation
Medical technology
Patient care
Practice guideline
Review
Symptom
Western hemisphere
World health organization
Aids
Diagnosis
Guidelines
Histoplasma
Histoplasmosis
Treatment
Rights
License
Abierto (Texto Completo)
id EDOCUR2_b2ae6f0d40cc346a4c60eaaf17172e51
oai_identifier_str oai:repository.urosario.edu.co:10336/23803
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 487b60dc-6389-4081-b3b9-39a3c8d7eec1-19bdea827-2516-464c-9885-8a4e2bf3cb54-118c9c410-81c8-465f-9b34-72c61fdcb5f6-1acf56719-6777-4ead-8ee6-2efd46de562a-111babe5e-2567-4150-a35a-f82b0f3bde88-1b94dd3ad-d417-44b1-a86d-21c4687ec66b-1d2dbd6b2-cb00-4891-9165-4d86a59d4f0d-1689305cb-2b49-46ee-bd68-7c8b17a3cf7f-129d74550-4f54-417d-8d7b-f51e6dc45a08-1d7594bcd-6ff3-49b7-9276-5940ae0f0b0d-13cd06428-6f44-48b9-a55c-41867ea13308-188c2ebc8-fcf4-4b52-bfa6-71c4e7c36766-1c91c568d-3609-4be3-b312-40d72e73b4f06002020-05-26T00:05:32Z2020-05-26T00:05:32Z2019Purpose of Review: The aim of this report is to summarize the conclusions of the II Regional Meeting on Histoplasmosis in the Americas held in Manaus, Brazil, on March 22–24, 2019. Recent Findings: Persons living with advanced HIV are at high risk for developing histoplasmosis. Clinical signs and symptoms of this disease are often non-specific, making it difficult to establish a diagnosis. Although with the recent technological advances, in vitro diagnostics and medicines for histoplasmosis are often not available in many regions around the world. In addition, histoplasmosis is often not included in HIV care and treatment programs, resulting in inadequate health system planning and missed opportunities to save lives. Summary: The II Regional Meeting on Histoplasmosis in the Americas gathered a multidisciplinary audience. Developed recommendations to be included in the WHO guidelines for diagnosis and treatment of histoplasmosis in advanced HIV were the product of this meeting, and guidelines are aimed to be published in early 2020. © 2019, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.application/pdfhttps://doi.org/10.1007/s12281-019-00365-3193637611936377Xhttps://repository.urosario.edu.co/handle/10336/23803engSpringer249No. 4244Current Fungal Infection ReportsVol. 13Current Fungal Infection Reports, ISSN:19363761, 1936377X, Vol.13, No.4 (2019); pp. 244-249https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075916707&doi=10.1007%2fs12281-019-00365-3&partnerID=40&md5=387a28f8811093d0bf388a8a314e9aefAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURItraconazoleAcquired immune deficiency syndromeBrazilClinical featureConsensus developmentDiagnostic testDisease severityDisease surveillanceHealth care organizationHealth care planningHealth programHigh risk patientHistoplasmosisHumanHuman immunodeficiency virus infected patientHuman immunodeficiency virus infectionIn vitro studyInternational cooperationMedical technologyPatient carePractice guidelineReviewSymptomWestern hemisphereWorld health organizationAidsDiagnosisGuidelinesHistoplasmaHistoplasmosisTreatmentThe Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy GrouparticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Caceres D.H.Adenis A.de Souza J.V.B.Gomez B.L.Cruz K.S.Pasqualotto A.C.Ravasi G.Perez F.Chiller T.de Lacerda M.V.G.Nacher M.The International Histoplasmosis Advocacy Group (iHAG)The International Histoplasmosis Advocacy Group (iHAG)10336/23803oai:repository.urosario.edu.co:10336/238032022-05-02 07:37:21.215825https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group
title The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group
spellingShingle The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group
Itraconazole
Acquired immune deficiency syndrome
Brazil
Clinical feature
Consensus development
Diagnostic test
Disease severity
Disease surveillance
Health care organization
Health care planning
Health program
High risk patient
Histoplasmosis
Human
Human immunodeficiency virus infected patient
Human immunodeficiency virus infection
In vitro study
International cooperation
Medical technology
Patient care
Practice guideline
Review
Symptom
Western hemisphere
World health organization
Aids
Diagnosis
Guidelines
Histoplasma
Histoplasmosis
Treatment
title_short The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group
title_full The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group
title_fullStr The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group
title_full_unstemmed The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group
title_sort The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group
dc.subject.keyword.spa.fl_str_mv Itraconazole
Acquired immune deficiency syndrome
Brazil
Clinical feature
Consensus development
Diagnostic test
Disease severity
Disease surveillance
Health care organization
Health care planning
Health program
High risk patient
Histoplasmosis
Human
Human immunodeficiency virus infected patient
Human immunodeficiency virus infection
In vitro study
International cooperation
Medical technology
Patient care
Practice guideline
Review
Symptom
Western hemisphere
World health organization
Aids
Diagnosis
Guidelines
Histoplasma
Histoplasmosis
Treatment
topic Itraconazole
Acquired immune deficiency syndrome
Brazil
Clinical feature
Consensus development
Diagnostic test
Disease severity
Disease surveillance
Health care organization
Health care planning
Health program
High risk patient
Histoplasmosis
Human
Human immunodeficiency virus infected patient
Human immunodeficiency virus infection
In vitro study
International cooperation
Medical technology
Patient care
Practice guideline
Review
Symptom
Western hemisphere
World health organization
Aids
Diagnosis
Guidelines
Histoplasma
Histoplasmosis
Treatment
description Purpose of Review: The aim of this report is to summarize the conclusions of the II Regional Meeting on Histoplasmosis in the Americas held in Manaus, Brazil, on March 22–24, 2019. Recent Findings: Persons living with advanced HIV are at high risk for developing histoplasmosis. Clinical signs and symptoms of this disease are often non-specific, making it difficult to establish a diagnosis. Although with the recent technological advances, in vitro diagnostics and medicines for histoplasmosis are often not available in many regions around the world. In addition, histoplasmosis is often not included in HIV care and treatment programs, resulting in inadequate health system planning and missed opportunities to save lives. Summary: The II Regional Meeting on Histoplasmosis in the Americas gathered a multidisciplinary audience. Developed recommendations to be included in the WHO guidelines for diagnosis and treatment of histoplasmosis in advanced HIV were the product of this meeting, and guidelines are aimed to be published in early 2020. © 2019, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
publishDate 2019
dc.date.created.spa.fl_str_mv 2019
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:05:32Z
dc.date.available.none.fl_str_mv 2020-05-26T00:05:32Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1007/s12281-019-00365-3
dc.identifier.issn.none.fl_str_mv 19363761
1936377X
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23803
url https://doi.org/10.1007/s12281-019-00365-3
https://repository.urosario.edu.co/handle/10336/23803
identifier_str_mv 19363761
1936377X
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 249
dc.relation.citationIssue.none.fl_str_mv No. 4
dc.relation.citationStartPage.none.fl_str_mv 244
dc.relation.citationTitle.none.fl_str_mv Current Fungal Infection Reports
dc.relation.citationVolume.none.fl_str_mv Vol. 13
dc.relation.ispartof.spa.fl_str_mv Current Fungal Infection Reports, ISSN:19363761, 1936377X, Vol.13, No.4 (2019); pp. 244-249
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075916707&doi=10.1007%2fs12281-019-00365-3&partnerID=40&md5=387a28f8811093d0bf388a8a314e9aef
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Springer
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167542110879744